Did You Know?

Editor’s Picks

Latest News

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology...

Custom Health Announces Closing of the Acquisition of InnovativeRx Operating Subsidiaries to Expand Integrated Medication Management Infrastructure Across North America

Strategic Acquisition: Custom Health announces the closing of the acquisition of substantially all of the operating assets of InnovativeRx US...

First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase

STOCKHOLM, June 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today...

Medmovie Launches HxHeart.com, Bringing Its Trusted Cardiovascular Education Library to Any Browser — and Releases a New Video on the Hidden Risks of Coronary Artery Disease

The same clinician-approved animations from the Hx Heart app are now available online at HxHeart.com — free, instantly, with no...

Nox Health Appoints Milton Silva-Craig as Chief Executive Officer to Accelerate Global Growth and Advance the Future of Sleep Health

Founder Sigurjón Kristjánsson to drive industry transformation and next-stage innovation as Founder and Vice Chairman.ALPHARETTA, Ga., June 9, 2026 /PRNewswire/...

XFERALL Unveils First of its Kind Patient InTake Suite Powered by aiXcel™ at Becker’s Healthcare, Marking a New Era in Behavioral Health Access

AUSTIN, Texas, June 9, 2026 /PRNewswire/ -- Across the United States, behavioral health patients are waiting hours, sometimes days, in...

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology

VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company")...

THX Pharma, Biocodex and the Beyond Batten Disease Foundation Stand Together with the CLN3 Batten Community on International Batten Disease Awareness Day

The three partners are proud to jointly serve as Platinum Sponsors of the 2026 BDSRA Annual Family Conference, where they...

error: Content is protected !!